Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma
-
* Corresponding author: Florian Eckel Florian.Eckel@lrz.tu-muenchen.de
BMC Cancer 2005, 5:61 doi:10.1186/1471-2407-5-61
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 15 Feb 2005 | |
| Reviewer's Report | Vittorio Gebbia | 30 Mar 2005 | |
| Reviewer's Report | Nicolas Tsavaris | 22 Apr 2005 | |
| Resubmission - Version 2 | 29 Apr 2005 | ||
| Resubmission - Version 3 | Manuscript | 29 Apr 2005 | |
| Reviewer's Report | Vittorio Gebbia | 20 May 2005 | |
| Reviewer's Report | Nicolas Tsavaris | 23 May 2005 | |
| Published | 12 Jun 2005 |